Andrew Sinclair's Net Worth
$882 Million
Who is Andrew Sinclair?
Andrew Sinclair has an estimated net worth of $882 Million. This is based on reported shares across multiple companies, which include Verona Pharma plc, Adicet Bio, Inc., Sierra Oncology, Inc., and SOLENO THERAPEUTICS INC.
SEC CIK
Andrew Sinclair's CIK is 0001762451
Past Insider Trading and Trends
2021 was Andrew Sinclair's most active year for acquiring shares with 10 total transactions. Andrew Sinclair's most active month to acquire stocks was the month of May. 2022 was Andrew Sinclair's most active year for disposing of shares, totalling 6 transactions. Andrew Sinclair's most active month to dispose stocks was the month of June. 2018 saw Andrew Sinclair paying a total of $7,499,784.69 for 9,358,544 shares, this is the most they've acquired in one year. In 2022 Andrew Sinclair cashed out on 2,487,097 shares for a total of $112,331,312.50, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Verona Pharma plc (VRNA) Snapshot price: $16.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 9
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Adicet Bio, Inc. (ACET) Snapshot price: $3.2175
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 14
| |||
Form 4
|
∞
| 5.9K |
—
|
—
| 5.9K |
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4/A
| +30.95% | 500K |
$14.00 | $7,000,000.00 | 2.12M |
Dec 8
| |||
Form 4
| +30.47% | 500K |
$14.00 | $7,000,000.00 | 2.14M |
Dec 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 30
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.31M |
$55.00 | -$72,276,985.00 |
0
|
Jul 1
| |||
Form 4
| +49.90% | 437.47K |
$17.93 | $7,844,617.20 | 1.31M |
Jan 28 - Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4/A
| +16,086.41% | 871.24K |
—
|
—
| 876.66K |
Jan 29
| |||
Form 4
| +16,081.32% | 871.13K |
—
|
—
| 876.54K |
Jan 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SOLENO THERAPEUTICS INC (SLNO) Snapshot price: $46.625
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 25 - May 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
| +74.93% | 7.72M |
—
|
—
| 18.02M |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
| +47.83% | 3.33M |
$1.65 | $5,499,994.50 | 10.3M |
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +49.26% | 2.3M |
$1.20 | $2,760,000.00 | 6.97M |
Oct 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
|
∞
| 4.67M |
$1.60 | $7,470,835.20 | 4.67M |
Dec 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||